GS0421: research and development of pharmaceuticals for others; research and development of pharmaceuticals for the treatment of cancer; research and development of pharmaceuticals for the treatment of inflammations; research and development of pharmaceuticals for the treatment of immune-mediated conditions; research and development of pharmaceuticals for the treatment of neuro-degenerative diseases; scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism
Case File Event Statements
1/15/2024 - 12 months ago
19 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILEDType:REM1